ArticleCancer chemotherapy and pharmacology2020

Physiologically based pharmacokinetic modeling to assess metabolic drug-drug interaction risks and inform the drug label for fedratinib.

Fan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.